(SeaPRwire) – NEW YORK CITY, NY – November 5, 2026 – (SeaPRwire) – As pharmaceutical companies increasingly seek measurable business outcomes from field engagement strategies, TikaMobile has launched TikaPharma, a new AI-native customer relationship management (CRM) platform specifically designed for commercial pharmaceutical sales teams. The platform enables sales teams to transition beyond traditional activity-based reporting and focus on real-time intelligence related to prescription performance, revenue impact, and informed decision-making regarding next-best actions.
TikaPharma addresses a persistent challenge in the pharmaceutical industry, where legacy CRM systems often emphasize metrics like call volume, email frequency, and activity tracking without clearly connecting these interactions to actual commercial results. By incorporating agentic artificial intelligence capabilities across the sales workflow, the platform offers field representatives and sales leadership teams more actionable operational insights.
The system can function as either a standalone commercial CRM solution or serve as an overlay that integrates with existing enterprise platforms, allowing organizations to adopt AI-driven features without replacing their current infrastructure.
Among its core functionalities is an AI-powered assistant capable of processing natural language queries from both sales representatives and managers. Users can request information such as trends in prescription declines, opportunities for healthcare provider engagement, territory performance reviews, or recommended next steps, with the system generating reports and strategic insights directly from live CRM data in real time.
TikaPharma also introduces TikaScore, a dynamic healthcare provider (HCP) prioritization engine intended to replace static segmentation models commonly used in pharmaceutical sales operations. This scoring framework continuously assesses prescribing momentum, engagement recency, payer conditions, and gaps in call plans to generate a real-time prioritization model tailored to each territory.
Leveraging this intelligence layer, the platform’s “Next Best Action” engine delivers personalized recommendations to sales representatives about which HCPs to engage, while the “Plan My Day” feature sequences field visits based on impact potential, urgency, and geographic efficiency. According to TikaMobile, the system can significantly reduce pre-call planning time for field teams.
In addition to supporting field-level activities, the platform includes smart alert capabilities for district managers, regional business directors, and executive leadership. Weekly AI-generated summaries identify potential risks—such as declining territory prescription trends, missed target HCP engagements, and incomplete call-plan execution—before they appear in traditional reporting metrics.
Manish Sharma, CEO of TikaMobile, noted that commercial pharmaceutical teams have historically relied on metrics that do not accurately reflect real business outcomes. He emphasized that TikaPharma was developed to help organizations shift toward intelligence models that directly link sales activities with prescription impact and commercial performance.
The platform is delivered through a configurable multi-tenant software-as-a-service (SaaS) architecture and forms part of TikaMobile’s broader life sciences technology portfolio. Other solutions within the suite include TikaMSL for Medical Affairs, TikaVEO for Medical Affairs Market Access, and TikaPayor for Commercial Market Access operations.
About TikaMobile
TikaMobile provides intelligent digital solutions for life sciences organizations, focusing on CRM, business intelligence, and AI-powered engagement platforms for both commercial and medical affairs teams. With over a decade of experience in the life sciences sector, the company supports more than 5,000 users globally and develops technology solutions aimed at optimizing healthcare professional engagement, streamlining workflows, and enhancing operational decision-making across multiple therapeutic areas.
This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content.
Category: Top News, Daily News
SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.